Back
Verizon Communications, Inc. Vs. Spyre Therapeutics, Inc. Industry Stock Comparison
Sell
47
VZ
Verizon Communications, Inc.
Last Price:
$49.28
Seasonality Move:
-1.04%
Buy
72
SYRE
Spyre Therapeutics, Inc.
Last Price:
$43.26
Seasonality Move:
-1.59%
Sell
47
Verizon Communications, Inc. (VZ)
is a Sell
Is Verizon Communications, Inc. a Buy, Sell or Hold?
-
The current Verizon Communications, Inc. [VZ] share price is $49.25. The Score for VZ is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
VZ is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
72
Spyre Therapeutics, Inc. (SYRE)
is a Buy
Is Spyre Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Spyre Therapeutics, Inc. [SYRE] share price is $43.21. The Score for SYRE is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
-
SYRE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VZ Stock Price Chart
What is Verizon Communications, Inc.'s stock price today?
-
The Verizon Communications, Inc. share price today is $49.25Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VZ is experiencing buying pressure, which is a positive indicator for future bullish movement.
SYRE Stock Price Chart
What is Spyre Therapeutics, Inc.'s stock price today?
-
The Spyre Therapeutics, Inc. share price today is $43.21Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SYRE is experiencing buying pressure, which is a positive indicator for future bullish movement.
VZ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.17 | Buy |
| Relative Strength Index (14 RSI): | 74.48 | Buy |
| Chaikin Money Flow: | 20113959 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (40.09 - 48.41) | Buy |
| Bollinger Bands (100): | (38.73 - 44.27) | Buy |
SYRE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.48 | Buy |
| Relative Strength Index (14 RSI): | 76.95 | Buy |
| Chaikin Money Flow: | 2001107 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (31.94 - 36.64) | Buy |
| Bollinger Bands (100): | (22.31 - 34.55) | Buy |
VZ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.71 | Buy |
| 20-day SMA: | 45.51 | Buy |
| 50-day SMA: | 42.27 | Buy |
| 200-day SMA: | 42.38 | Buy |
| 8-day EMA: | 25.81 | Buy |
| 20-day EMA: | 12.63 | Buy |
| 50-day EMA: | 5.5 | Buy |
| 200-day EMA: | 1.44 | Buy |
SYRE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.57 | Buy |
| 20-day SMA: | 34.45 | Buy |
| 50-day SMA: | 33.41 | Buy |
| 200-day SMA: | 22.2 | Buy |
| 8-day EMA: | 21.06 | Buy |
| 20-day EMA: | 10.23 | Buy |
| 50-day EMA: | 4.44 | Buy |
| 200-day EMA: | 1.16 | Buy |
Verizon Communications, Inc. Earnings Growth & VZ Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.23 per share, and an increase next year of $0.34 per share.
Spyre Therapeutics, Inc. Earnings Growth & SYRE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.46 per share, a decrease this year of $0.85 per share, and an increase next year of $0.08 per share.
Verizon Communications, Inc. Technical Analysis
| Feb 6 | Feb 9 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 17 | Feb 18 | Feb 19 | Feb 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Spyre Therapeutics, Inc. Technical Analysis
| Feb 6 | Feb 9 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 17 | Feb 18 | Feb 19 | Feb 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||